查看購物車
  • Simplified Chinese
  • English
南美洲和中美洲直接面對消費者的基因測試市場預測至 2030 年 - 區域分析 - 按測試類型、技術和配銷通路
市場調查報告書
商品編碼
1463706

南美洲和中美洲直接面對消費者的基因測試市場預測至 2030 年 - 區域分析 - 按測試類型、技術和配銷通路

South & Central America Direct-to-Consumer Genetic Testing Market Forecast to 2030 - Regional Analysis - by Test Type, Technology, and Distribution Channel
出版日期: | 出版商: The Insight Partners | 英文 61 Pages | 訂單完成後即時交付

價格

2022年，中南美洲直接面對消費者的基因檢測市場價值為8,964萬美元，預計2030年將達到3.4985億美元；預計2022年至2030年CAGR為18.6%。

單核苷酸多態性 (SNP) 晶片的日益普及推動了南美洲和中美洲直接面對消費者的基因檢測市場

近年來，隨著科學知識的增加，從傳統醫學向個人化醫學的典範穩步轉變。這種轉變歸功於基因工程、單核苷酸多態性 (SNP) 基因分型以及微陣列和生物晶片技術的廣泛採用。具有數十萬個 SNP 的基因微陣列分析平台的引入將鼓勵先進演算法的實施，以更公開地測試個體之間更隱蔽的家譜關係。此外，檢測惡性腫瘤的需求也有所增加。在兒科領域，由於無需將 SNP 變異與大規模缺失雜交，週轉時間短，因此產生了巨大的需求。因此，隨著更多基因異常的檢測和治療，市場預計將會成長。

由於對技術先進和更複雜的 DTC 基因檢測的持續需求，高效、準確的 SNP 晶片的需求不斷增加。人們對 SNP 晶片的高度偏好可歸因於它們能夠測量劑量變化和 DNA 多態性，以及對癌症研究至關重要的各種應用，例如 SNP 微陣列分析。此外，對盡量減少 DTC 基因檢測錯誤的需求日益成長，預計將推動 SNP 技術的採用，為市場成長提供機會。

南美洲和中美洲直接面對消費者的基因檢測市場概述

南美洲和中美洲直接面對消費者的基因檢測市場分為巴西、阿根廷以及南美洲和中美洲其他地區。該地區的市場受到遺傳性疾病發病率迅速上升、老年人口不斷成長、醫療保健系統的發展以及基因檢測意識不斷提高等因素的推動。遺傳疾病以及慢性病盛行率的上升是推動巴西 DTC 基因檢測市場成長的主要因素。例如，遺傳性疾病和先天畸形共同構成巴西嬰兒死亡的第二大常見原因。對個人化醫療的需求不斷成長，疾病診斷新技術的引入，以及行業參與者對開發新診斷技術以提供更快、更準確的結果的關注，預計將成為有利於直接面對消費者的成長的其他值得注意的因素巴西的基因檢測市場。隨著科學家保證追蹤有助於治療肥胖和糖尿病等現代疾病流行的遺傳特徵，巴西的醫學遺傳學領域不斷擴大。此外，巴西私人基因檢測公司（尤其是提供親子鑑定解決方案的公司）的數量正在增加。 2019年，巴西領先的基因檢測實驗室之一GENOMIKA與Veritas簽署協議，將後者與預防醫學和臨床遺傳學相關的全基因組和外顯子組定序服務納入其產品組合。

南美洲和中美洲直接面對消費者的基因檢測市場收入及 2030 年預測（百萬美元）

南美洲和中美洲直接面對消費者的基因檢測市場區隔

南美洲和中美洲直接面對消費者的基因檢測市場分為測試類型、技術、配銷通路和國家。

根據測試類型，南美洲和中美洲直接面對消費者的基因測試市場分為血統測試、預測測試、營養基因組學測試、帶因者測試等。 2022 年，血統測驗細分市場佔據最大佔有率。

從技術面來看，中南美洲直接面對消費者的基因檢測市場分為全基因組定序、單核苷酸多態性晶片、標靶分析等。 2022年，單核苷酸多態性晶片領域佔據最大佔有率。

根據配銷通路，南美洲和中美洲直接面對消費者的基因檢測市場分為線上和線下。 2022 年，線上細分市場佔據了更大的佔有率。

根據國家/地區，南美洲和中美洲直接面對消費者的基因檢測市場分為巴西、阿根廷以及南美洲和中美洲其他地區。 2022 年，巴西在南美洲和中美洲直接面對消費者的基因檢測市場佔據主導地位。

Ancestry Genomics Inc、Living DNA Ltd、23andMe Inc 和 Genetic Technologies Ltd 是南美洲和中美洲直接面對消費者基因檢測市場的一些領先公司。

目錄

表中的內容

第 1 章：簡介

第 2 章：執行摘要

  • 重要見解

第 3 章：研究方法

  • 覆蓋範圍
  • 二次研究
  • 初步研究

第 4 章：南美洲和中美洲直接面對消費者的基因檢測市場模式

  • 概述

第 5 章：南美洲和中美洲直接面對消費者的基因檢測市場 - 主要產業動態

  • 市場促進因素
    • 遺傳性疾病的發生率不斷上升
    • 提高對基因檢測潛在益處的認知
  • 市場限制
    • 與直接面對消費者的基因檢測相關的高成本和隱私問題
  • 市場機會
    • 單核苷酸多態性 (SNP) 晶片的採用日益廣泛
  • 未來的趨勢
    • 人們對藥物基因學的興趣日益濃厚，遠距醫療的採用也不斷增加
  • 影響分析

第 6 章：直接面對消費者的基因檢測市場 - 南美洲和中美洲市場分析

  • 概述
  • 南美洲和中美洲直接面對消費者的基因檢測市場收入，2022 - 2030

第 7 章：南美洲和中美洲直接面對消費者的基因測試市場 - 收入和 2030 年預測 - 按測試類型

  • 概述
  • 2022 年和 2030 年南美洲和中美洲直接面對消費者的基因測試市場收入佔有率（按測試類型分類）
  • 血統測試
  • 營養基因組學測試
  • 預測測試
  • 營運商測試
  • 其他

第 8 章：南美洲和中美洲直接面對消費者的基因檢測市場 - 收入和 2030 年預測 - 按技術分類

  • 概述
  • 2022 年和 2030 年南美洲和中美洲直接面對消費者的基因檢測市場收入佔有率（按技術分類）
  • 全基因組定序
  • 單核苷酸多態性晶片
  • 針對性分析
  • 其他

第 9 章：南美洲和中美洲直接面對消費者的基因檢測市場 - 收入和 2030 年預測 - 按配銷通路

  • 概述
  • 2022 年和 2030 年南美洲和中美洲直接面對消費者的基因檢測市場收入佔有率（按配銷通路分類）（%）
  • 線上平台
  • 線下平台

第 10 章：南美洲和中美洲直接面對消費者的基因檢測市場 - 收入和 2030 年預測 - 國家分析

  • 巴西
  • 阿根廷
  • 餘下的

第 11 章：南美洲和中美洲直接面對消費者的基因檢測市場-產業格局

  • 概述
  • 有機發展
    • 概述
  • 無機發展
    • 概述

第 12 章：公司簡介

  • Ancestry Genomics Inc
  • Living DNA Ltd
  • 23andMe Inc
  • Genetic Technologies Ltd

第 13 章：附錄

Product Code: BMIRE00029626

The South & Central America direct-to-consumer genetic testing market was valued at US$ 89.64 million in 2022 and is expected to reach US$ 349.85 million by 2030; it is estimated to grow at a CAGR of 18.6% from 2022 to 2030.

Growing Adoption of Single Nucleotide Polymorphism (SNP) Chips Fuels the South & Central America Direct-to-Consumer Genetic Testing Market

There has been a steady paradigm shift from traditional medicine to personalized medicine with increasing scientific knowledge in recent years. This shift is due to advances in genetic engineering, single nucleotide polymorphism (SNP) genotyping, and the high adoption of microarrays and biochip technologies. The introduction of genetic microarray analysis platforms with hundreds of thousands of SNPs will encourage the implementation of advanced algorithms to test for more secluded genealogical relationships more openly between individuals. In addition, the demand for detecting malignant tumors has also increased. In the pediatric field, the short turnaround time without the need to hybridize SNP variations to massive deletions has led to enormous demand. As a result, the market is expected to grow as more genetic abnormalities are detected and treated.

SNP chips with high efficiency and accuracy are witnessing an increase in demand due to the constant need for technologically advanced and more sophisticated DTC genetic testing. A high preference for SNP chips can be attributed to their ability to measure dosage changes and DNA polymorphism, along with various applications such as the SNP microarray analysis that are vital for cancer research. Furthermore, an increasing need to minimize errors in DTC genetic testing is expected to drive the adoption of SNP technology, thereby providing an opportunity for the market growth.

South & Central America Direct-to-Consumer Genetic Testing Market Overview

The South & Central America direct-to-consumer genetic testing market is segmented into Brazil, Argentina, and the Rest of South & Central America. The market in this region is driven by factors such as the burgeoning incidences of genetic disorders, the growing geriatric population, developments in healthcare systems, and rising awareness about genetic testing. The rising prevalence of the genetic disease, along with chronic illness, is the primary factor driving the growth of Brazil's DTC genetic testing market. For instance, genetic diseases and congenital abnormalities together represent the second most common cause of mortality among infants in Brazil. The growing demand for personalized medicines, introduction of novel technologies in disease diagnosis, and focus of industry players on developing new diagnostic techniques to provide faster results with high accuracy are expected to be other noteworthy factors to favor the growth of the direct-to-consumer genetic testing market in Brazil. The field of medical genetics has expanded in Brazil as scientists assure to track down genetic traits that will help to treat modern disease epidemics, such as obesity and diabetes. Moreover, the number of private genetic testing companies, particularly offering paternity testing solutions, is on the rise in Brazil. In 2019, GENOMIKA, one of the leading genetic testing laboratories in Brazil, signed an agreement with Veritas to incorporate the latter's Whole Genome and Exome Sequencing services associated with preventive medicine and clinical genetics into its portfolio.

South & Central America Direct-to-Consumer Genetic Testing Market Revenue and Forecast to 2030 (US$ Million)

South & Central America Direct-to-Consumer Genetic Testing Market Segmentation

The South & Central America direct-to-consumer genetic testing market is segmented into test type, technology, distribution channel, and country.

Based on test type, the South & Central America direct-to-consumer genetic testing market is segmented into ancestry testing, predictive testing, nutrigenomics testing, carrier testing, and others. The ancestry testing market segment held the largest share in 2022.

In terms of technology, the South & Central America direct-to-consumer genetic testing market is categorized into whole genome sequencing, single nucleotide polymorphism chips, targeted analysis, and others. The single nucleotide polymorphism chips segment held the largest share in 2022.

Based on distribution channel, the South & Central America direct-to-consumer genetic testing market is bifurcated into online , and offline. The online segment held a larger share in 2022.

Based on country, the South & Central America direct-to-consumer genetic testing market is segmented the Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the South & Central America direct-to-consumer genetic testing market in 2022.

Ancestry Genomics Inc, Living DNA Ltd, 23andMe Inc, and Genetic Technologies Ltd are some of the leading companies operating in the South & Central America direct-to-consumer genetic testing market.

Table Of Contents

Table of Content

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. South & Central America Direct-to-Consumer Genetic Testing Market Landscape

  • 4.1 Overview

5. South & Central America Direct-to-Consumer Genetic Testing Market - Key Industry Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Growing Incidence of Genetic Disorders
    • 5.1.2 Increasing Awareness About Potential Benefits of Genetic Testing
  • 5.2 Market Restraints
    • 5.2.1 High Cost and Privacy Concerns Associated With Direct-to-Consumer Genetic Testing
  • 5.3 Market Opportunities
    • 5.3.1 Growing Adoption of Single Nucleotide Polymorphism (SNP) Chips
  • 5.4 Future Trends
    • 5.4.1 Growing Interest in Pharmacogenetics and Increasing Adoption of Telehealth
  • 5.5 Impact Analysis

6. Direct-to-Consumer Genetic Testing Market - South & Central America Market Analysis

  • 6.1 Overview
  • 6.2 South & Central America Direct-to-Consumer Genetic Testing Market Revenue (US$ Mn), 2022 - 2030

7. South & Central America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 - by Test Type

  • 7.1 Overview
  • 7.2 South & Central America Direct-to-Consumer Genetic Testing Market Revenue Share, by Test Type 2022 & 2030 (%)
  • 7.3 Ancestry Testing
    • 7.3.1 Overview
    • 7.3.2 Ancestry Testing: South & Central America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Nutrigenomics Testing
    • 7.4.1 Overview
    • 7.4.2 Nutrigenomics Testing: South & Central America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Predictive Testing
    • 7.5.1 Overview
    • 7.5.2 Predictive Testing: South & Central America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.6 Carrier Testing
    • 7.6.1 Overview
    • 7.6.2 Carrier Testing: South & Central America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.7 Others
    • 7.7.1 Overview
    • 7.7.2 Others: South & Central America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)

8. South & Central America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 - by Technology

  • 8.1 Overview
  • 8.2 South & Central America Direct-to-Consumer Genetic Testing Market Revenue Share, by Technology 2022 & 2030 (%)
  • 8.3 Whole Genome Sequencing
    • 8.3.1 Overview
    • 8.3.2 Whole Genome Sequencing: South & Central America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Single Nucleotide Polymorphism Chips
    • 8.4.1 Overview
    • 8.4.2 Single Nucleotide Polymorphism Chips: South & Central America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Targeted Analysis
    • 8.5.1 Overview
    • 8.5.2 Targeted Analysis: South & Central America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Others
    • 8.6.1 Overview
    • 8.6.2 Others: South & Central America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)

9. South & Central America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 - by Distribution Channel

  • 9.1 Overview
  • 9.2 South & Central America Direct-to-Consumer Genetic Testing Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
  • 9.3 Online Platform
    • 9.3.1 Overview
    • 9.3.2 Online Platform: South & Central America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Offline Platform
    • 9.4.1 Overview
    • 9.4.2 Offline Platform: South & Central America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)

10. South & Central America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 - Country Analysis

  • 10.1 South & Central America Direct-to-Consumer Genetic Testing Market, By Key Country - Revenue (2022) (US$ Million)
    • 10.1.1 South & Central America Direct-to-Consumer Genetic Testing Market Share by Country - 2022 & 2030, (%)
      • 10.1.1.1 Brazil: South & Central America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (USD Million)
      • 10.1.1.2 Brazil: South & Central America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.2.1 Brazil: South & Central America Direct-to-Consumer Genetic Testing Market, by Test Type, 2020-2030 (US$ Million)
        • 10.1.1.2.2 Brazil: South & Central America Direct-to-Consumer Genetic Testing Market, By Technology, 2020-2030 (US$ Million)
        • 10.1.1.2.3 Brazil: South & Central America Direct-to-Consumer Genetic Testing Market, By Distribution Channel, 2020-2030 (US$ Million)
      • 10.1.1.3 Argentina: South & Central America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (USD Million)
      • 10.1.1.4 Argentina: South & Central America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.4.1 Argentina: South & Central America Direct-to-Consumer Genetic Testing Market, by Test Type, 2020-2030 (US$ Million)
        • 10.1.1.4.2 Argentina: South & Central America Direct-to-Consumer Genetic Testing Market, By Technology, 2020-2030 (US$ Million)
        • 10.1.1.4.3 Argentina: South & Central America Direct-to-Consumer Genetic Testing Market, By Distribution Channel, 2020-2030 (US$ Million)
      • 10.1.1.5 Rest of South & Central America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (USD Million)
      • 10.1.1.6 Rest of South & Central America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.6.1 Rest of South & Central America Direct-to-Consumer Genetic Testing Market, by Test Type, 2020-2030 (US$ Million)
        • 10.1.1.6.2 Rest of South & Central America Direct-to-Consumer Genetic Testing Market, By Technology, 2020-2030 (US$ Million)
        • 10.1.1.6.3 Rest of South & Central America Direct-to-Consumer Genetic Testing Market, By Distribution Channel, 2020-2030 (US$ Million)

11. South & Central America Direct-to-Consumer Genetic Testing Market-Industry Landscape

  • 11.1 Overview
  • 11.2 Organic Developments
    • 11.2.1 Overview
  • 11.3 Inorganic Developments
    • 11.3.1 Overview

12. Company Profiles

  • 12.1 Ancestry Genomics Inc
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Living DNA Ltd
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 23andMe Inc
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Genetic Technologies Ltd
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments

13. Appendix

  • 13.1 About Us
  • 13.2 Glossary of Terms

List Of Tables

  • Table 1. South & Central America Direct-to-Consumer Genetic Testing Market Segmentation
  • Table 2. Brazil: South & Central America Direct-to-Consumer Genetic Testing Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 3. Brazil: South & Central America Direct-to-Consumer Genetic Testing Market, By Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 4. Brazil: South & Central America Direct-to-Consumer Genetic Testing Market, By Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 5. Argentina: South & Central America Direct-to-Consumer Genetic Testing Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 6. Argentina: South & Central America Direct-to-Consumer Genetic Testing Market, By Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 7. Argentina: South & Central America Direct-to-Consumer Genetic Testing Market, By Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 8. Rest of South & Central South & Central America Direct-to-Consumer Genetic Testing Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 9. Rest of South & Central America Direct-to-Consumer Genetic Testing Market, By Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 10. Rest of South & Central America Direct-to-Consumer Genetic Testing Market, By Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 11. Organic Developments Done by Companies
  • Table 12. Inorganic Developments Done by Companies
  • Table 13. Glossary of Terms, South & Central America Direct-to-Consumer Genetic Testing Market

List Of Figures

  • Figure 1. South & Central America Direct-to-Consumer Genetic Testing Market Segmentation, By Country
  • Figure 2. South & Central America Direct-to-Consumer Genetic Testing Market: Key Industry Dynamics
  • Figure 3. South & Central America Direct-to-Consumer Genetic Testing Market: Impact Analysis of Drivers and Restraints
  • Figure 4. South & Central America Direct-to-Consumer Genetic Testing Market Revenue (US$ Mn), 2020 - 2030
  • Figure 5. South & Central America Direct-to-Consumer Genetic Testing Market Revenue Share, by Test Type 2022 & 2030 (%)
  • Figure 6. Ancestry Testing: South & Central America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 7. Nutrigenomics Testing: South & Central America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Predictive Testing: South & Central America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Carrier Testing: South & Central America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Others: South & Central America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. South & Central America Direct-to-Consumer Genetic Testing Market Revenue Share, by Technology 2022 & 2030 (%)
  • Figure 12. Whole Genome Sequencing: South & Central America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Single Nucleotide Polymorphism Chips: South & Central America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Targeted Analysis: South & Central America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Others: South & Central America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. South & Central America Direct-to-Consumer Genetic Testing Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
  • Figure 17. Online Platform: South & Central America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Offline Platform: South & Central America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. South & Central America Direct-to-Consumer Genetic Testing Market, By Key Country - Revenue (2022) (US$ Million)
  • Figure 20. South & Central America Direct-to-Consumer Genetic Testing Market Share by Country - 2022 & 2030, (%)
  • Figure 21. Brazil: South & Central America Direct-to-Consumer Genetic Testing Market- Revenue and Forecasts to 2030 (US$ Million)
  • Figure 22. Argentina: South & Central America Direct-to-Consumer Genetic Testing Market- Revenue and Forecasts to 2030 (US$ Million)
  • Figure 23. Rest of South & Central America Direct-to-Consumer Genetic Testing Market - Revenue and Forecast to 2030 (US$ Million)